Logo image of IMAX

IMAX CORP (IMAX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:IMAX - CA45245E1097 - Common Stock

37.61 USD
+0.18 (+0.48%)
Last: 1/20/2026, 4:10:03 PM
37.61 USD
0 (0%)
After Hours: 1/20/2026, 4:10:03 PM
Fundamental Rating

5

IMAX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 80 industry peers in the Entertainment industry. Both the profitability and the financial health of IMAX get a neutral evaluation. Nothing too spectacular is happening here. IMAX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • IMAX had positive earnings in the past year.
  • IMAX had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: IMAX reported negative net income in multiple years.
  • Of the past 5 years IMAX 4 years had a positive operating cash flow.
IMAX Yearly Net Income VS EBIT VS OCF VS FCFIMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.45%, IMAX is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • IMAX has a Return On Equity of 11.31%. This is in the better half of the industry: IMAX outperforms 80.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 7.73%, IMAX belongs to the top of the industry, outperforming 82.50% of the companies in the same industry.
  • IMAX had an Average Return On Invested Capital over the past 3 years of 4.23%. This is below the industry average of 8.70%.
  • The last Return On Invested Capital (7.73%) for IMAX is above the 3 year average (4.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.45%
ROE 11.31%
ROIC 7.73%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
IMAX Yearly ROA, ROE, ROICIMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • The Profit Margin of IMAX (10.47%) is better than 83.75% of its industry peers.
  • In the last couple of years the Profit Margin of IMAX has declined.
  • IMAX has a better Operating Margin (19.91%) than 91.25% of its industry peers.
  • In the last couple of years the Operating Margin of IMAX has declined.
  • IMAX has a better Gross Margin (58.89%) than 66.25% of its industry peers.
  • In the last couple of years the Gross Margin of IMAX has remained more or less at the same level.
Industry RankSector Rank
OM 19.91%
PM (TTM) 10.47%
GM 58.89%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
IMAX Yearly Profit, Operating, Gross MarginsIMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IMAX is destroying value.
  • Compared to 1 year ago, IMAX has less shares outstanding
  • The number of shares outstanding for IMAX has been reduced compared to 5 years ago.
  • IMAX has a worse debt/assets ratio than last year.
IMAX Yearly Shares OutstandingIMAX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IMAX Yearly Total Debt VS Total AssetsIMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 2.80 indicates that IMAX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of IMAX (2.80) is better than 72.50% of its industry peers.
  • IMAX has a debt to FCF ratio of 2.85. This is a good value and a sign of high solvency as IMAX would need 2.85 years to pay back of all of its debts.
  • The Debt to FCF ratio of IMAX (2.85) is better than 80.00% of its industry peers.
  • A Debt/Equity ratio of 0.74 indicates that IMAX is somewhat dependend on debt financing.
  • IMAX has a Debt to Equity ratio of 0.74. This is in the lower half of the industry: IMAX underperforms 61.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 2.85
Altman-Z 2.8
ROIC/WACC0.82
WACC9.39%
IMAX Yearly LT Debt VS Equity VS FCFIMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • IMAX has a Current Ratio of 2.47. This indicates that IMAX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.47, IMAX is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • A Quick Ratio of 2.12 indicates that IMAX has no problem at all paying its short term obligations.
  • IMAX has a better Quick ratio (2.12) than 77.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 2.12
IMAX Yearly Current Assets VS Current LiabilitesIMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 32.94% over the past year.
  • Measured over the past years, IMAX shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.17% on average per year.
  • IMAX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.30%.
  • Measured over the past years, IMAX shows a decrease in Revenue. The Revenue has been decreasing by -2.30% on average per year.
EPS 1Y (TTM)32.94%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%34.29%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%16.62%

3.2 Future

  • The Earnings Per Share is expected to grow by 20.13% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, IMAX will show a small growth in Revenue. The Revenue will grow by 6.43% on average per year.
EPS Next Y44.58%
EPS Next 2Y33.1%
EPS Next 3Y24.06%
EPS Next 5Y20.13%
Revenue Next Year11.56%
Revenue Next 2Y10.23%
Revenue Next 3Y9.18%
Revenue Next 5Y6.43%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMAX Yearly Revenue VS EstimatesIMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
IMAX Yearly EPS VS EstimatesIMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 33.28, IMAX can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, IMAX is valued a bit cheaper than the industry average as 78.75% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of IMAX to the average of the S&P500 Index (27.38), we can say IMAX is valued slightly more expensively.
  • Based on the Price/Forward Earnings ratio of 22.35, the valuation of IMAX can be described as rather expensive.
  • 80.00% of the companies in the same industry are more expensive than IMAX, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 24.29. IMAX is around the same levels.
Industry RankSector Rank
PE 33.28
Fwd PE 22.35
IMAX Price Earnings VS Forward Price EarningsIMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IMAX indicates a somewhat cheap valuation: IMAX is cheaper than 66.25% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of IMAX indicates a rather cheap valuation: IMAX is cheaper than 81.25% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.42
EV/EBITDA 15.68
IMAX Per share dataIMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • IMAX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • IMAX has a very decent profitability rating, which may justify a higher PE ratio.
  • IMAX's earnings are expected to grow with 24.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.75
PEG (5Y)N/A
EPS Next 2Y33.1%
EPS Next 3Y24.06%

0

5. Dividend

5.1 Amount

  • No dividends for IMAX!.
Industry RankSector Rank
Dividend Yield 0%

IMAX CORP

NYSE:IMAX (1/20/2026, 4:10:03 PM)

After market: 37.61 0 (0%)

37.61

+0.18 (+0.48%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)10-23
Earnings (Next)02-17
Inst Owners93%
Inst Owner Change0.06%
Ins Owners19.21%
Ins Owner Change-0.27%
Market Cap2.02B
Revenue(TTM)377.68M
Net Income(TTM)39.55M
Analysts82.22
Price Target44.46 (18.21%)
Short Float %11.42%
Short Ratio3.42
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.48%
Min EPS beat(2)20.24%
Max EPS beat(2)20.72%
EPS beat(4)3
Avg EPS beat(4)11.61%
Min EPS beat(4)-6.42%
Max EPS beat(4)20.72%
EPS beat(8)7
Avg EPS beat(8)65.63%
EPS beat(12)10
Avg EPS beat(12)54.13%
EPS beat(16)11
Avg EPS beat(16)15.31%
Revenue beat(2)0
Avg Revenue beat(2)-1.01%
Min Revenue beat(2)-1.46%
Max Revenue beat(2)-0.56%
Revenue beat(4)1
Avg Revenue beat(4)-3.09%
Min Revenue beat(4)-11.37%
Max Revenue beat(4)1.04%
Revenue beat(8)2
Avg Revenue beat(8)-0.56%
Revenue beat(12)6
Avg Revenue beat(12)1.35%
Revenue beat(16)7
Avg Revenue beat(16)2.11%
PT rev (1m)11.75%
PT rev (3m)25.83%
EPS NQ rev (1m)1.1%
EPS NQ rev (3m)-7.58%
EPS NY rev (1m)0.56%
EPS NY rev (3m)8.73%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-2.65%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 33.28
Fwd PE 22.35
P/S 5.36
P/FCF 22.42
P/OCF 18.53
P/B 5.79
P/tB 8.05
EV/EBITDA 15.68
EPS(TTM)1.13
EY3%
EPS(NY)1.68
Fwd EY4.47%
FCF(TTM)1.68
FCFY4.46%
OCF(TTM)2.03
OCFY5.4%
SpS7.02
BVpS6.5
TBVpS4.67
PEG (NY)0.75
PEG (5Y)N/A
Graham Number12.85
Profitability
Industry RankSector Rank
ROA 4.45%
ROE 11.31%
ROCE 9.75%
ROIC 7.73%
ROICexc 9.49%
ROICexgc 14.13%
OM 19.91%
PM (TTM) 10.47%
GM 58.89%
FCFM 23.9%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
ROICexc(3y)4.84%
ROICexc(5y)N/A
ROICexgc(3y)7.01%
ROICexgc(5y)N/A
ROCE(3y)5.33%
ROCE(5y)N/A
ROICexgc growth 3Y113.18%
ROICexgc growth 5Y-5.75%
ROICexc growth 3Y103.14%
ROICexc growth 5Y-8.28%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
F-Score8
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 2.85
Debt/EBITDA 1.9
Cap/Depr 31.29%
Cap/Sales 5.01%
Interest Coverage 250
Cash Conversion 80.47%
Profit Quality 228.24%
Current Ratio 2.47
Quick Ratio 2.12
Altman-Z 2.8
F-Score8
WACC9.39%
ROIC/WACC0.82
Cap/Depr(3y)25.16%
Cap/Depr(5y)18.94%
Cap/Sales(3y)4.33%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.94%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%34.29%
EPS Next Y44.58%
EPS Next 2Y33.1%
EPS Next 3Y24.06%
EPS Next 5Y20.13%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%16.62%
Revenue Next Year11.56%
Revenue Next 2Y10.23%
Revenue Next 3Y9.18%
Revenue Next 5Y6.43%
EBIT growth 1Y94.17%
EBIT growth 3Y108.21%
EBIT growth 5Y-9.36%
EBIT Next Year234.24%
EBIT Next 3Y63.05%
EBIT Next 5Y38.42%
FCF growth 1Y52.72%
FCF growth 3YN/A
FCF growth 5Y-7.57%
OCF growth 1Y52.91%
OCF growth 3Y126.45%
OCF growth 5Y-4.76%

IMAX CORP / IMAX FAQ

Can you provide the ChartMill fundamental rating for IMAX CORP?

ChartMill assigns a fundamental rating of 5 / 10 to IMAX.


Can you provide the valuation status for IMAX CORP?

ChartMill assigns a valuation rating of 6 / 10 to IMAX CORP (IMAX). This can be considered as Fairly Valued.


What is the profitability of IMAX stock?

IMAX CORP (IMAX) has a profitability rating of 6 / 10.


What is the earnings growth outlook for IMAX CORP?

The Earnings per Share (EPS) of IMAX CORP (IMAX) is expected to grow by 44.58% in the next year.